- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
PDS Biotechnology Corp (PDSB)
Assess today's live PDS Biotechnology Corp (PDSB) share price, performance and insights using our live NASDAQ: PDSB stock exchange data.
Analyse the historical data and PDS Biotechnology Corp share price performance charts on this page. Our technical summary section provides analysis on PDS Biotech share price buy/sell indicators using real-time data (or discuss the PDS Biotech (PDSB) stock price today with other investors in the PDS Biotech NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ PDSB share price (ISIN: US70465T1079) to enhance your trading decisions with our free investment tools and resources.
What Is the PDS Biotechnology Corp Share Price Today?
The PDS Biotech share price today is 0.870.
What Is the Stock Symbol for PDS Biotechnology Corp
The stock symbol (or 'ticker') for PDS Biotechnology Corp is "PDSB."
What Stock Exchange Does PDS Biotechnology Corp Trade On?
PDS Biotechnology Corp is listed and trades on the NASDAQ stock exchange.
Is PDS Biotechnology Corp a Good Stock to Buy?
Determining whether PDS Biotechnology Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and PDS Biotechnology Corp share price performance charts on this page. Our technical summary section provides analysis on PDS Biotech share price buy/sell indicators using real-time data (or discuss the PDS Biotech (PDSB) stock price today with other investors in the PDS Biotech NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ PDSB share price (ISIN: US70465T1079) to enhance your trading decisions with our free investment tools and resources.
What Is the PDS Biotechnology Corp Share Price Today?
The PDS Biotech share price today is 0.870.
What Is the Stock Symbol for PDS Biotechnology Corp
The stock symbol (or 'ticker') for PDS Biotechnology Corp is "PDSB."
What Stock Exchange Does PDS Biotechnology Corp Trade On?
PDS Biotechnology Corp is listed and trades on the NASDAQ stock exchange.
Is PDS Biotechnology Corp a Good Stock to Buy?
Determining whether PDS Biotechnology Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.865
0.914
52 wk Range
0.703
2.200
PDSB is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.8650.914
52 wk Range
0.7032.200
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PDSB Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
7.500
Upside
+762.07%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
PDS Biotech Company Profile
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies. The company’s lead product candidate is Versamune HPV, which is in phase II clinical trial for the treatment of head and neck, cervical, anal, vaginal, vulvar, and penile cancers. It also develops various product candidates, which are in preclinical trials, including PDS0102, an investigational immunotherapy utilizing tumor-associated and immunologically active T cell receptor gamma alternate reading framed protein for treating acute myeloid leukemia, prostate, and breast cancer; and PDS0103 for ovarian, breast, colorectal, and lung cancers. In addition, the company is developing PDS01ADC, a novel investigational Interleukin 12 fused antibody-drug conjugate, tumor-targeting interleukin 12 immune-cytokine that enhances the proliferation, potency, and longevity of T cells in the tumor microenvironment. Further, the company provides PDS0202, a novel investigational influenza vaccine that protects against the strains predicted to be prevalent in an upcoming flu season. It has a license and collaboration agreements with National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, and MSD International GmbH. PDS Biotechnology Corporation was founded in 2005 and is based in Princeton, New Jersey.
PDS Biotechnology Corp Earnings Call Summary for Q3/2025
- PDS Biotech reported Q3 2025 net loss of $9M (-$0.19 per share), beating analyst expectations of -$0.2133 and showing improvement from -$0.29 in Q3 2024.
- R&D expenses decreased to $4.6M from $6.8M year-over-year, while cash reserves declined significantly to $26.2M from $41.7M at the beginning of 2025.
- The company is advancing its HPV-16 targeted immunotherapy platform PDS0101, seeking FDA approval to use progression-free survival as a primary endpoint in clinical trials.
- Stock experienced volatility following the earnings announcement, initially dropping 9.06% before regaining 1.66% in premarket trading to reach $0.98.
- Management remains optimistic about their strategic focus on HPV-16 positive head and neck cancer, though significant cash burn raises concerns about future liquidity.
Last Updated: 13/11/2025, 14:12
Read Full TranscriptCompare PDSB to Peers and Sector
Metrics to compare | PDSB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPDSBPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.4x | −3.9x | −0.6x | |
PEG Ratio | −0.05 | 0.09 | 0.00 | |
Price/Book | 5.0x | 2.5x | 2.6x | |
Price / LTM Sales | - | 376.4x | 3.2x | |
Upside (Analyst Target) | - | 159.3% | 41.8% | |
Fair Value Upside | Unlock | −13.7% | 5.1% | Unlock |
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 7.500
(+762.07% Upside)
Earnings
Latest Release
Nov 13, 2025
EPS / Forecast
-0.19 / -0.21
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the PDS Biotech (PDSB) Share Price Today?
The live PDS Biotech share price today is 0.870
What Stock Exchange Does PDS Biotech (PDSB) Trade On?
PDS Biotech is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for PDS Biotech?
The stock symbol (also called a 'ticker') for PDS Biotech is "PDSB."
What Is the Current PDS Biotech Market Cap?
As of today, PDS Biotech market capitalisation is 47.61M.
What Is PDS Biotech's (PDSB) Earnings Per Share (TTM)?
The PDS Biotech EPS is currently -0.81 (Trailing Twelve Months).
When Is the Next PDS Biotech Earnings Date?
PDS Biotech's next earnings report will be released on 26 Mar 2026.
Is PDSB a Buy or Sell From a Technical Analyst Perspective?
Based on today's PDS Biotech moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has PDS Biotech Stock Split?
PDS Biotech has split 1 times. (See the PDSB stock split history page for full effective split date and price information.)
How Many Employees Does PDS Biotech Have?
PDS Biotech has 24 employees.
What is the current trading status of PDS Biotech (PDSB)?
As of 24 Dec 2025, PDS Biotech (PDSB) is trading at a price of 0.870, with a previous close of 0.870. The stock has fluctuated within a day range of 0.865 to 0.914, while its 52-week range spans from 0.703 to 2.200.
What Is PDS Biotech (PDSB) Price Target According to Analysts?
The average 12-month price target for PDS Biotech is USD7.5, with a high estimate of USD15 and a low estimate of USD3. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +762.07% Upside potential.
What Is the PDSB After Hours Price?
PDSB's last after hours stock price is 0.840, the stock has decreased by -0.030, or -3.450%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.